Haploidentical bone marrow transplantation for severe aplastic anaemia: looking to the future

Affiliations

¹ Haematology and Bone Marrow Transplant Unit, AORN Moscati, Avellino 83100, Italy. Electronic address: camilla.frieri@aornmoscati.it.
² Haematology and Bone Marrow Transplant Unit, AORN Moscati, Avellino 83100, Italy.

Comment

Camilla Frieri et al. Lancet Haematol. 2022 Sep.

. 2022 Sep;9(9):e629-e630.

doi: 10.1016/S2352-3026(22)00242-3. Epub 2022 Jul 27.

¹ Haematology and Bone Marrow Transplant Unit, AORN Moscati, Avellino 83100, Italy. Electronic address: camilla.frieri@aornmoscati.it.
² Haematology and Bone Marrow Transplant Unit, AORN Moscati, Avellino 83100, Italy.

No abstract available

Conflict of interest statement

We declare no competing interests.

Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.
DeZern AE, Eapen M, Wu J, Talano JA, Solh M, Dávila Saldaña BJ, Karanes C, Horwitz ME, Mallhi K, Arai S, Farhadfar N, Hexner E, Westervelt P, Antin JH, Deeg HJ, Leifer E, Brodsky RA, Logan BR, Horowitz MM, Jones RJ, Pulsipher MA. DeZern AE, et al. Lancet Haematol. 2022 Sep;9(9):e660-e669. doi: 10.1016/S2352-3026(22)00206-X. Epub 2022 Jul 27. Lancet Haematol. 2022. PMID: 35907408 Free PMC article. Clinical Trial.